New-onset atrial fibrillation (AF) is a common complication after transcatheter aortic valve replacement (TAVR), though estimates of the precise occurence are variable. We sought to quantify the occurence of new-onset AF after TAVR and to explore the outcomes and predictors associated with this complication.

Editors

JACC: Cardiovascular Interventions Editor-in-Chief

David J. Moliterno, MD, FACC

JACC: Cardiovascular Interventions CME/MOC/ECME Editor

Michael C. McDaniel, MD

Authors

Tammy Ryan, MD, PhD
Emilie P. Belley-Coté, MD, PhD
William F. McIntyre, MD, PhD

Important Dates

Date of Release: March 21, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: March 20, 2023